serena williams glp-1 commercial Ro makes Super Bowl debut with to shift narrative from 'vanity' to 'vitals' Serena Williams weight loss GLP-1

It is unclear whether using one drug over another yields differences in cardiovascular outcomes

Despite reasonably successful progress in clinical trials of its most advanced oral candidate danuglipron, the company halted development in April, owing to a possible drug-induced liver injury in one participant of an earlier study

doi: 10.1007/bf00495663 36 MentleinR

doi: 10.1111/dom.12539

Until now, Medicare beneficiaries have had to pay out of pocket for the obesity drugs, costing them potentially hundreds of dollars a month

GLP-1 medications like Wegovy and Mounjaro offer a scientifically-backed solution, with studies showing they can help individuals lose weight more effectively compared to lifestyle changes alone